Inhibition of KDM5B participates in immune microenvironment remodeling in pancreatic cancer by inducing STING expression

被引:2
|
作者
Li, Xuesong [1 ,2 ]
Li, Jiazhuang [1 ]
Liu, Ying [1 ]
Sun, Li [1 ]
Tai, Qingyang [1 ]
Gao, Shoubao [1 ]
Jiang, Weiwei [1 ]
机构
[1] Qiqihar Med Univ, Affiliated Hosp 3, Dept Oncol 2, Qiqihar, Heilongjiang, Peoples R China
[2] Qiqihar Med Univ, Affiliated Hosp 3, Dept Oncol 2, 3 TaiShun St, Qiqihar, Heilongjiang, Peoples R China
关键词
Pancreatic cancer; KDM5B; Demethylation; STING; Immunity; Microenvironment remodeling; Antitumor ability; DEMETHYLASES;
D O I
10.1016/j.cyto.2023.156451
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Objective: This study aims to investigate the effect of lysine demethylase 5B (KDM5B)-mediated dimethyl-lysine 4 histone H3 (H3K4me2) demethylation on immune microenvironment remodeling in pancreatic cancer. Methods: Pan 02 mouse pancreatic cancer cell lines were cultured and used to establish tumor model in vivo. RTqPCR and Western blot were used to detect the expression of stimulator of interferon gene (STING) and KDM5B in pancreatic cancer tissues and Pan 02 cells. The specific demethylation domain of KDM5B was detected by isothermal titration calorimetry binding assay. The regulatory roles of KDM5B in cell apoptosis and remodeling of immune microenvironment in vitro and in vivo were explored after loss-of functions in KDM5B. Results: KDM5B was highly expressed but STING was poorly expressed in pancreatic cancer tissues and Pan 02 cells. After knockdown of KDM5B, CD8+ T cells recognized and killed Pan 02 cells, which promoted the infiltration of CD8+ T cells in Pan 02 cells, thus improving the anti-tumor ability. The PHD domain in KDM5B specifically bound to H3K4me2 peptide and inhibition of KDM5B induced STING expression. Knockdown of KDM5B up-regulated STING expression to promote apoptosis, thus regulating the immune microenvironment and inhibiting the growth of tumor in mice. Meanwhile, knockdown of KDM5B and STING simultaneously counteracted the knockdown effect of KDM5B. Conclusion: Inhibition of KDM5B can promote the expression of STING through H3K4me2 demethylation, which promoted the recognition and killing of Pan 02 cells by CD8+ T cells, thus improving the anti-tumor ability and regulating the immune microenvironment.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
    Jing, Weiqing
    McAllister, Donna
    Vonderhaar, Emily P.
    Palen, Katie
    Riese, Matthew J.
    Gershan, Jill
    Johnson, Bryon D.
    Dwinell, Michael B.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [32] KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 family
    Enkhbaatar, Zanabazar
    Terashima, Minoru
    Oktyabri, Dulamsuren
    Tange, Shoichiro
    Ishimura, Akihiko
    Yano, Seiji
    Suzuki, Takeshi
    CELL CYCLE, 2013, 12 (13) : 2100 - 2112
  • [33] Loss of KDM5B ameliorates pathological cardiac fibrosis and dysfunction by epigenetically enhancing ATF3 expression
    Wang, Bo
    Tan, Yong
    Zhang, Yunkai
    Zhang, Sheng
    Duan, Xuewen
    Jiang, Yuyu
    Li, Tong
    Zhou, Qingqing
    Liu, Xingguang
    Zhan, Zhenzhen
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2022, 54 (12): : 2175 - 2187
  • [34] Loss of KDM5B ameliorates pathological cardiac fibrosis and dysfunction by epigenetically enhancing ATF3 expression
    Bo Wang
    Yong Tan
    Yunkai Zhang
    Sheng Zhang
    Xuewen Duan
    Yuyu Jiang
    Tong Li
    Qingqing Zhou
    Xingguang Liu
    Zhenzhen Zhan
    Experimental & Molecular Medicine, 2022, 54 : 2175 - 2187
  • [35] Deficiency or targeting inhibition of histone lysine demethylase KDM5B in vivo for potential therapeutic effects on both HFrEF and HFpEF
    Zhao, Wen
    Qiao, Hui
    Wang, Ziwei
    Wang, Meifei
    Wang, Haopeng
    Wang, Wenlong
    Wang, Qiqi
    Tan, Shixuan
    Jiao, Lemin
    Xu, Jiale
    Li, Yalan
    Gao, Erhe
    Yuan, Ziqiao
    Liu, Hong-Min
    Dong, Jianzeng
    Yu, Bin
    CIRCULATION RESEARCH, 2024, 135
  • [36] Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448
    Oluwaseun Adebayo Bamodu
    Wen-Chien Huang
    Wei-Hwa Lee
    Alexander Wu
    Liang Shun Wang
    Michael Hsiao
    Chi-Tai Yeh
    Tsu-Yi Chao
    BMC Cancer, 16
  • [37] USP38 protein alleviates neuroinflammation of cerebral ischemia–reperfusion injury via KDM5B expression
    Hongru Wang
    Xinhong Xue
    Molecular & Cellular Toxicology, 2021, 17 : 465 - 473
  • [38] LncRNA HOXC-AS3 accelerates malignant proliferation of cervical cancer cells via stabilizing KDM5B
    Li, Jie
    Hou, Fang
    Teng, Zhenghua
    Xia, Weiwei
    Peng, Jie
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (06)
  • [39] Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448
    Bamodu, Oluwaseun Adebayo
    Huang, Wen-Chien
    Lee, Wei-Hwa
    Wu, Alexander
    Wang, Liang Shun
    Hsiao, Michael
    Yeh, Chi-Tai
    Chao, Tsu-Yi
    BMC CANCER, 2016, 16
  • [40] CUX2/KDM5B/SOX17 Axis Affects the Occurrence and Development of Breast Cancer
    Li, Lili
    Zhu, Genbao
    Tan, Kemeng
    Jiang, La
    Li, Yafen
    Zhu, Xiaohong
    Lin, Zongwu
    Zhang, Xinghai
    Chen, Jie
    Ma, Chengquan
    ENDOCRINOLOGY, 2022, 163 (09)